Renal denervation and treatment of hypertension

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Interventional Cardiology

Background:

• Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, with hypertension as a major risk factor.
• Ischaemic heart disease and stroke account for millions of deaths annually.
• Current treatments, including pharmacological agents and lifestyle changes, are insufficient for many patients due to incomplete understanding of molecular mechanisms.

Purpose of the Study:

• To review novel approaches for treating cardiovascular diseases, focusing on renal denervation.
• To discuss the evolution of renal denervation techniques, from early attempts to modern catheter-based interventions.
• To highlight the improvements and consequences associated with catheter-based renal nerve ablation.

Main Methods:

• Review of existing literature on renal denervation for hypertension and cardiovascular disease.
• Discussion of historical methods of renal artery denervation.
• Analysis of outcomes from catheter-based renal nerve ablation procedures.

Main Results:

• Catheter-based renal nerve ablation represents a significant advancement over previous denervation attempts.
• This minimally invasive technique offers improved outcomes for patients unresponsive to conventional therapies.
• The review details the progress and implications of applying this novel interventional approach.

Conclusions:

• Renal nerve ablation, particularly catheter-based methods, offers a promising therapeutic option for resistant hypertension and associated cardiovascular conditions.
• Further research into the molecular mechanisms underlying hypertension is crucial for developing more effective treatments.
• Minimally invasive techniques like renal denervation are expanding treatment possibilities for complex cardiovascular diseases.